跳至主要内容
临床试验/JPRN-UMIN000026022
JPRN-UMIN000026022已完成未知

Treatment of glucocorticoid induced hyperglycemia in patients with type 2 diabetes mellitus with omarigliptin at Okayama university hospital: an open label randomized controlled trial - Good-MOMO study

Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences0 个研究点目标入组 70 人开始时间: 2017年4月19日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Type 1 diabetes mellitus 2) Concomitant glucocorticoid pulse therapy 3) Treated with insulin or dipeptidyl peptidase-4 inhibitor 4) Malignancy 5) Pregnant or breastfeeding 6) Difficulty in taking pills 7) Autoimmune pancreatitis 8) Patients who are considered as inappropriate for attending this study by their physicians

研究者

发起方
Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences

相似试验

Treatment of glucocorticoid induced hyperglycemia in... | 临床试验